May 8, 2024 Freyja HealthCare's VereSee™ Device Receives 510(k) Clearance, the First of Many Products Read more Jun 25, 2024 Freyja Healthcare Secures $8M in New Funding and Appoints Tracy MacNeal as Independent Board Director Read more Patents Our VereSee is covered by one or more of the following patents as indicated below. Beyond this, Freyja Healthcare maintains a robust patent portfolio supporting future pipeline of products with 30 patents granted 50 patents filed 20 patents pending VereSee™ Freyja Healthcare’s VereSee™ or aspects thereof, are covered by one or more of the patents and patent applications listed below: U.S. Patent No. 11,051,851 U.S. Patent No. 11,382,662 U.S. Patent No. 11,051,851 U.S. Patent Application No. 17/368,296 U.S. Patent Application No. 18/905,729 European Patent Application No. EP18840663.1 European Patent Application No. EP22743016.2 Japanese Patent No. JP7208993B2 Japanese Patent Application No. JP2023568160 Chinese Patent Application No. CN202280019774.1 VereSee™ Freyja Healthcare’s VereSee™ or aspects thereof, are covered by one or more of the patents and patent applications listed below: U.S. Patent No. 11,051,851 U.S. Patent No. 11,382,662 U.S. Patent No. 11,051,851 U.S. Patent Application No. 17/368,296 U.S. Patent Application No. 18/905,729 European Patent Application No. EP18840663.1 European Patent Application No. EP22743016.2 Japanese Patent No. JP7208993B2 Japanese Patent Application No. JP2023568160 Chinese Patent Application No. CN202280019774.1 Interested in Learning More? Request a Demo Today. REQUEST A DEMO CONTACT US